• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN? EL ICD DR; Implantable Cardioverter Defibrillator

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN? EL ICD DR; Implantable Cardioverter Defibrillator Back to Search Results
Model Number D153
Medical Device Problem Codes Defibrillation/Stimulation Problem (1573); Inappropriate/Inadequate Shock/Stimulation (1574)
Health Effect - Clinical Code Tachycardia (2095)
Date of Event 05/31/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This product investigation is still in progress.This report will be updated when product investigation is complete.If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that while this implantable cardioverter defibrillator (icd) was delivering anti-tachycardia pacing (atp) for ventricular fibrillation, an inappropriate shock was delivered that accelerated the rhythm into a short burst of ventricular tachycardia (vt).Technical services (ts) was consulted to review episodes and confirmed the initial condition was patient related and that atp was highly successful.Ts noted the patient received one inappropriate shock after atp had converted, creating the short burst of vt.Ts determined that therapy was never exhausted and gave system and patient related recommendations based on the episodes reviewed.
 
Event or Problem Description
It was reported that while this implantable cardioverter defibrillator (icd) was delivering anti-tachycardia pacing (atp) for ventricular fibrillation, an inappropriate shock was delivered that accelerated the rhythm into a short burst of ventricular tachycardia (vt).Technical services (ts) was consulted to review episodes and confirmed the initial condition was patient related and that atp was highly successful.Ts noted the patient received one inappropriate shock after atp had converted, creating the short burst of vt.Ts determined that therapy was never exhausted and gave system and patient related recommendations based on the episodes reviewed.
 
Additional Manufacturer Narrative
The device was not returned for analysis; therefore, a technical analysis could not be performed.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of rhythm acceleration was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.A similar complaint review was completed using global similar complaint review tool, which reviewed as reported device code 2278: rhythm acceleration and did not identify any emerging trends or similar complaints that require escalation.However a review for the as reported impact code f1009: inappropriate treatment identified that this was a new code introduced in feb 2026 increased trend was the result of the usage and implementation of this code by cmc, which does not represent a change in product performance.No escalation is required.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN? EL ICD DR
Common Device Name
Implantable Cardioverter Defibrillator
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
Boston Scientific Corporation
cashel road
clonmel
EI  
Manufacturer Contact
mark mischke
4100 hamline avenue north
saint paul, MN 55112
+1(612)875-7234
MDR Report Key25610817
Report Number2124215-2026-33574
Device Sequence Number9942172
Product Code LWS
UDI-Device Identifier00802526534829
UDI-Public(01)00802526534829(17)180913
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P960040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/27/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date09/13/2018
Device Model NumberD153
Device Catalogue NumberD153
Device Lot Number205925
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/01/2026
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date06/24/2026
Supplement Report FDA Received Date09/04/2026
Date Device Manufactured11/23/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age77 YR
Patient SexMale
-
-